1. Home
  2. XLO vs TRSG Comparison

XLO vs TRSG Comparison

Compare XLO & TRSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XLO
  • TRSG
  • Stock Information
  • Founded
  • XLO 2016
  • TRSG 1996
  • Country
  • XLO United States
  • TRSG Singapore
  • Employees
  • XLO N/A
  • TRSG N/A
  • Industry
  • XLO Biotechnology: Pharmaceutical Preparations
  • TRSG
  • Sector
  • XLO Health Care
  • TRSG
  • Exchange
  • XLO Nasdaq
  • TRSG NYSE
  • Market Cap
  • XLO 42.1M
  • TRSG 35.2M
  • IPO Year
  • XLO 2021
  • TRSG 2024
  • Fundamental
  • Price
  • XLO $1.11
  • TRSG $2.21
  • Analyst Decision
  • XLO Buy
  • TRSG
  • Analyst Count
  • XLO 1
  • TRSG 0
  • Target Price
  • XLO $4.00
  • TRSG N/A
  • AVG Volume (30 Days)
  • XLO 738.6K
  • TRSG 17.6K
  • Earning Date
  • XLO 11-07-2024
  • TRSG 02-15-2025
  • Dividend Yield
  • XLO N/A
  • TRSG N/A
  • EPS Growth
  • XLO N/A
  • TRSG N/A
  • EPS
  • XLO N/A
  • TRSG 0.06
  • Revenue
  • XLO $4,620,000.00
  • TRSG $14,362,502.00
  • Revenue This Year
  • XLO N/A
  • TRSG N/A
  • Revenue Next Year
  • XLO $368.76
  • TRSG N/A
  • P/E Ratio
  • XLO N/A
  • TRSG $35.72
  • Revenue Growth
  • XLO N/A
  • TRSG N/A
  • 52 Week Low
  • XLO $0.50
  • TRSG $2.06
  • 52 Week High
  • XLO $1.93
  • TRSG $11.78
  • Technical
  • Relative Strength Index (RSI)
  • XLO 54.59
  • TRSG N/A
  • Support Level
  • XLO $0.84
  • TRSG N/A
  • Resistance Level
  • XLO $1.28
  • TRSG N/A
  • Average True Range (ATR)
  • XLO 0.13
  • TRSG 0.00
  • MACD
  • XLO 0.01
  • TRSG 0.00
  • Stochastic Oscillator
  • XLO 62.72
  • TRSG 0.00

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).

About TRSG TUNGRAY TECHNOLOGIES INC

Tungray Technologies Inc is an engineer-to-order company that provides custom industrial manufacturing solutions to original equipment manufacturers in the semiconductor, printer, electronics, and home appliance industries. It predominantly generates revenue through the manufacture of custom industrial manufacturing solutions, direct drive and linear DC motors, and induction welding equipment. Geographically, the company generates a majority of its revenue from Singapore and the rest from China.

Share on Social Networks: